A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON)

Ossenkoppele, GJ; van der Holt, B; Sonneveld, P; Vellenga, E; Verdonck, L; Biesma, D; Westveer, P; Peters, G; Noordhuis, P; Muus, P; Graveland, W; Schaafsma, M; Selleslag, D; Delforge, Michel; Lowenberg, B; Verhoef, Gregor

Blood

A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON)

Author:

Ossenkoppele, GJ

van der Holt, B ; Sonneveld, P ; Vellenga, E ; Verdonck, L ; Biesma, D ; Westveer, P ; Peters, G ; Noordhuis, P ; Muus, P ; Graveland, W ; Schaafsma, M ; Selleslag, D ; Delforge, Michel ; Lowenberg, B ; Verhoef, Gregor

Keywords:

Science & Technology, Life Sciences & Biomedicine, Hematology, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Immunology, 3101 Biochemistry and cell biology, 3201 Cardiovascular medicine and haematology, 3213 Paediatrics

Blood A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON)

Author:

Keywords:

Blood

A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON)